Sign Up
av/jubilant-life-sciences--big.svg

COM:JUBILANTPHARMOVA

Jubilant Pharmova

  • Stock

Last Close

1,138.50

25/11 06:31

Market Cap

115.38B

Beta: -

Volume Today

98.31K

Avg: -

OverviewAnalysisMetricsFinancialsFilingspeopleAPIChartData
Income StatementBalance SheetCash FlowKey MetricsRatios
Quarterly
Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Mar '14
Jun '14
Sep '14
Dec '14
Mar '15
Jun '15
Sep '15
Dec '15
Mar '16
Jun '16
Sep '16
Dec '16
Mar '17
Jun '17
Sep '17
Dec '17
Mar '18
Jun '18
Sep '18
Dec '18
Mar '19
Jun '19
Sep '19
Dec '19
Mar '20
Jun '20
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
net income
1.43B
-
988.10M
31.11%
47.80M
95.16%
-941.10M
2,068.83%
-111.60M
88.14%
427.26M
482.85%
1.28B
199.72%
1.16B
9.56%
1.17B
0.96%
310.21M
73.47%
1.62B
420.94%
1.45B
10.41%
1.20B
17.26%
1.50B
24.81%
1.47B
1.58%
1.28B
12.83%
2.13B
65.71%
1.55B
27.14%
2.02B
30.76%
2.10B
3.91%
2.61B
23.97%
-992.94M
138.07%
1.85B
286.30%
2.49B
34.82%
2.03B
18.45%
2.60B
28.08%
880.10M
66.21%
2.24B
154.55%
3.10B
38.34%
2.14B
30.98%
1.61B
24.94%
1.43B
11.04%
509.90M
64.30%
595.46M
16.78%
470.40M
21.00%
54.90M
88.33%
-156.70M
385.43%
-978.40M
524.38%
64M
106.54%
625M
876.56%
668M
6.88%
-586M
187.72%
4.82B
922.70%
depreciation and amortization
939.50M
-
942.80M
0.35%
2.71B
187.69%
897M
66.93%
966M
7.69%
946M
2.07%
deferred income tax
stock based compensation
5.32M
-
10K
-
2.46M
-
11.24M
-
36.52M
-
change in working capital
accounts receivables
inventory
accounts payables
other working capital
other non cash items
-1.43B
-
-988.10M
31.11%
-47.80M
95.16%
941.10M
2,068.83%
111.60M
88.14%
-427.26M
482.85%
-1.28B
199.72%
-1.16B
9.56%
-1.17B
0.96%
-315.53M
73.02%
-1.62B
412.15%
-1.45B
10.41%
-1.20B
17.26%
-1.50B
24.82%
-1.47B
1.58%
-1.28B
12.83%
-2.13B
65.71%
-1.55B
27.14%
-2.02B
30.76%
-2.10B
3.91%
-2.61B
23.97%
992.94M
138.07%
-1.85B
286.30%
-2.49B
34.82%
-2.03B
18.45%
-2.60B
28.08%
-880.10M
66.21%
-2.24B
154.55%
-3.10B
38.34%
-2.14B
30.91%
-1.61B
25.02%
-1.43B
11.04%
-509.90M
64.30%
-606.70M
18.98%
-470.40M
22.47%
884.60M
288.05%
1.10B
24.29%
-1.73B
257.70%
833M
148.04%
341M
59.06%
278M
18.48%
586M
110.79%
-4.82B
922.70%
net cash provided by operating activities
5.32M
-
10K
-
2.46M
-
11.24M
-
1.88B
-
1.89B
0.35%
36.52M
98.06%
1.79B
4,812.38%
1.93B
7.69%
1.89B
2.07%
investments in property plant and equipment
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
debt repayment
common stock issued
common stock repurchased
dividends paid
other financing activites
net cash used provided by financing activities
effect of forex changes on cash
net change in cash
5.32M
-
10K
-
2.46M
-
11.24M
-
1.88B
-
1.89B
0.35%
36.52M
98.06%
1.79B
4,812.38%
1.93B
7.69%
1.89B
2.07%
cash at beginning of period
6.58B
-
8.46B
28.57%
10.10B
19.48%
10.14B
0.36%
7.80B
23.02%
9.74B
24.75%
cash at end of period
5.32M
-
10K
-
2.46M
-
11.24M
-
8.46B
-
10.34B
22.30%
10.14B
1.95%
11.93B
17.69%
9.74B
18.40%
11.63B
19.43%
operating cash flow
5.32M
-
10K
-
2.46M
-
11.24M
-
1.88B
-
1.89B
0.35%
36.52M
98.06%
1.79B
4,812.38%
1.93B
7.69%
1.89B
2.07%
capital expenditure
free cash flow
5.32M
-
10K
-
2.46M
-
11.24M
-
1.88B
-
1.89B
0.35%
36.52M
98.06%
1.79B
4,812.38%
1.93B
7.69%
1.89B
2.07%

All numbers in (except ratios and percentages)